Industry Insights

Industry Insights

A deeper dive into the pharmaceutical industry

Indication-based agreements – A key enabler of UK access to combination therapies in oncologyIndication-based agreements – A key enabler of UK access to combination therapies in oncology
Indication-based agreements – A key enabler of UK access to combination therapies in oncology

Jonathan Bowen from Sanofi UK and Ireland explains how indication-based agreements can remove barriers to patient access to combination cancer therapies

Aug 24, 2023 Industry Insights
How statistical and data analysis can support research innovations in rare diseasesHow statistical and data analysis can support research innovations in rare diseases
How statistical and data analysis can support research innovations in rare diseases

Giles Partington, Lindsay Govan, Paddy O’Hara, Emily Foreman and Jennifer Visser-Rogers from Phastar consider how data can be used to improve research innovations in rare diseases

Aug 24, 2023 Industry Insights
Seven ways to boost HCP engagement through field behavioural changeSeven ways to boost HCP engagement through field behavioural change
Seven ways to boost HCP engagement through field behavioural change

Veeva talks to Pharmafocus about the best ways that biopharma companies can boost their engagement

Aug 24, 2023 Industry Insights
Why modelling patient heterogeneity is crucial in drug developmentWhy modelling patient heterogeneity is crucial in drug development
Why modelling patient heterogeneity is crucial in drug development

Prof Shai Shen-Orr at Cytoreason explores the need for patient heterogeneity in drug development, and suggests why this is so central to successful drug development

May 25, 2023 Industry Insights
How regulators are keeping pace with technologyHow regulators are keeping pace with technology
How regulators are keeping pace with technology

Fiona Maini from Medidata Solutions, speaks about pharmaceutical regulation and the opportunities and policy challenges posed by digitalisation and a rapidly evolving industry

May 25, 2023 Industry Insights
Connected drug delivery devices: considerations for developing digitised combination productsConnected drug delivery devices: considerations for developing digitised combination products
Connected drug delivery devices: considerations for developing digitised combination products

Michael Earl, director of pharmaceutical services at Owen Mumford, considers the benefits of connectivity and how this can be best utilised by pharma companies

Apr 30, 2023 Industry Insights
Compounded Medication: What Do We Need To Know?Compounded Medication: What Do We Need To Know?
Compounded Medication: What Do We Need To Know?

Rizvan Faruk Batha from Specialist Pharmacy tells Pharmafocus about the history and benefits of compounded medication and why it’s not as common in the UK as the rest of Europe, North America and Australia

Apr 2, 2023 Industry Insights
Removing Uncertainty In The Supply ChainRemoving Uncertainty In The Supply Chain
Removing Uncertainty In The Supply Chain

Nikunj Desai, head of supply chain at ACG, explores how supply chains can be made more secure and the impacts this may have on the pharma industry

Mar 6, 2023 Industry Insights
The Future Of Follicular Lymphoma TreatmentThe Future Of Follicular Lymphoma Treatment
The Future Of Follicular Lymphoma Treatment

The Follicular Lymphoma Foundation tells Pharmafocus about new research being conducted into blood cancer follicular lymphoma and their new research grant programme

Dec 1, 2022 Industry Insights
Over 90% Of Vaccines In UK Imported From FlandersOver 90% Of Vaccines In UK Imported From Flanders
Over 90% Of Vaccines In UK Imported From Flanders

Why do such a significant amount of vaccines in the UK come from Flanders and what does this mean in the ongoing COVID-19 pandemic?

Dec 1, 2022 Industry Insights
Ypsomed And Sidekick Seek Digital Solution To Self-injection AnxietyYpsomed And Sidekick Seek Digital Solution To Self-injection Anxiety
Ypsomed And Sidekick Seek Digital Solution To Self-injection Anxiety

Patients who need to regularly inject themselves can often experience needle anxiety and worry that they may not be able to carry out the procedure correctly each time, which can reduce compliance. With Sidekick, Ypsomed intends to adopt a digital approach to combat this problem, through the development of a molecule specifically targeted towards patients with chronic conditions who need to self-inject therapies on a regular basis.

Oct 27, 2022 Industry Insights
Routine Hospital Care Postponed Due To National Bank HolidayRoutine Hospital Care Postponed Due To National Bank Holiday
Routine Hospital Care Postponed Due To National Bank Holiday

Opinions have been divided as thousand of NHS operations and appointments were cancelled or postponed due to Queen Elizabeth II’s state funeral, on Monday 19 September. Some patients have cancelled their own appointments, where others have complained of the disruption.

Oct 27, 2022 Industry Insights